Stallergenes SA’s Oralair Beats Merck’s Grastek To Market, But With Limited Label
This article was originally published in The Pink Sheet Daily
Executive Summary
Oral grass allergy immunotherapy becomes the first alternative to allergy shots; modified indication, boxed warning reflects advisory panel recommendations.